Stanley E. Gilliland III

Stan is the Practice Lead for Materials Science with Consilium Sciences, LLC. His specialty includes investigating complex material science and addressing regulatory science through a varied background in nanotechnology, chemistry, engineering, and biotechnology.  Stan received his BS in biotechnology from James Madison University, MS in chemistry from Virginia Commonwealth University, and PhD in nanoscience and nanotechnology from Virginia Commonwealth University. He completed a postdoctoral training in chemical and life science engineering at Virginia Commonwealth University. Stan is an author on 12 peer-reviewed publications in leading chemistry and material science journals.

Currently, he leads the tobacco regulatory team at Consilium which supports numerous clients as they prepare for Premarket Tobacco Product Application (PMTA), Substantial Equivalence (SE), and Tobacco Product Masterfile (TPMF) submittals. He often leads projects by guiding clients through every step of the complex tobacco regulatory process including designing regulatory-facing studies or submitting regulatory applications. In addition to his project leadership and management expertise, he often specifically focuses on the chemistry aspects of regulatory submissions including nonclinical study design and data analytics. He is well versed in all areas of tobacco regulatory including chemistry, manufacturing, and control (CMC), nonclinical studies, and clinical studies as well as compiling all information and studies of a PMTA into the electronic tobacco technical document (eTTD) format.


Consilium employs a core group of full-time, senior-level Principal Scientists, combined with the broader Consilium Scientific Network of more than 300 consultants from across the globe.  This unique distributed-consulting approach allows us to build cost-efficient, project-specific teams that solve our clients’ needs quickly and effectively.  Typically, a Consilium project team will have one or more of our full-time consultants leading the project. Our teams are custom-built and project-specific, ranging in size from one individual up to a 40-person team. At Consilium, we present goals, explain requirements, embark on study design, conduct research, develop strategy, and prepare complete regulatory submissions. Consilium also supports clients beyond submission with follow-up correspondence, responses to deficiency letters, post-market surveillance, and design and execution of annual reporting requirements.